glp-1 cardiovascular outcomes trial results august 2025 Kidney and Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials SGLTi and GLP-1 in HF
Description
This hormone was first identified in the 1990s and pharmaceutical drugs were developed shortly after to mimic its effects
Similarly, GLP-1RA have shown to have a neuroprotective effect including delay in Alzheimers and Parkinsons disease onset as well progressions (118)
These changes also support better hormone balance and immune function
Liraglutide alleviates hepatic steatosis by activating the TFEB-regulated autophagy-lysosomal pathway
Adverse events related to tirzepatide
